Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 9
Submit an article Journal homepage
605
Views
2
CrossRef citations to date
0
Altmetric
Letters

Seroprevalence of anti-mumps virus IgG antibody titer and voluntary mumps vaccination coverage in young adults in Japan

Hiraku Sasakia Department of Health Science, Faculty of Health and Sports Science, Juntendo University, Inzai, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6452-5349
ORCID Icon,
Tomoko Fukunagab Section of Health Management, Faculty of Health and Sports Science, Juntendo University, Inzai, Japan
,
Ai Asanob Section of Health Management, Faculty of Health and Sports Science, Juntendo University, Inzai, Japan
,
Kansuke Yamanakaa Department of Health Science, Faculty of Health and Sports Science, Juntendo University, Inzai, Japan
,
Kota Oikawaa Department of Health Science, Faculty of Health and Sports Science, Juntendo University, Inzai, Japan
&
Nobuto Shibatac Department of Psychiatry, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan
Pages 3153-3155 | Received 17 Mar 2021, Accepted 01 Apr 2021, Published online: 20 Apr 2021

References

  • Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;371(9616):932–944. doi:10.1016/S0140-6736(08)60419-5.
  • Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ. 2005;330(7500):1132–35. doi:10.1136/bmj.330.7500.1132.
  • Almansour I. Mumps vaccines: current challenges and future prospects. Front Microbiol. 2020;11:1999. doi:10.3389/fmicb.2020.01999.
  • Fujinaga T, Motegi Y, Tamura H, Kuroume T. A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine. Pediatr Infect Dis J. 1991;10(3):204–09. doi:10.1097/00006454-199103000-00007.
  • Sugiura A, Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J. 1991;10(3):209–13. doi:10.1097/00006454-199103000-00008.
  • Infectious Diseases Surveillance Center, National Institute of Infectious Diseases and Ministry of Health and Welfare, Japan. Mumps vaccination status by age group in Japan. FY2015‐National epidemiological surveillance of vaccine-preventable diseases, Japan. IASR. 2016;37:198–99.
  • Infectious Diseases Surveillance Center, National Institute of Infectious Diseases and Ministry of Health and Welfare, Japan. Changes in seropositivity before and after the 2010–2011 mumps epidemic. IASR 2016. 2010–11 mumps epidemic;37:199–201.
  • Ohfuji S, Takagi A, Nakano T, Kumihashi H, Kano M, Tanaka T. Mumps-related disease burden in Japan: analysis of JMDC health insurance reimbursement data for 2005–2017. J Epidemiol. 2020. doi:10.2188/jea.JE20200048.
  • Gouma S, Schurink-Van’t Klooster TM, De Melker HE, Kerkhof J, Smits GP, Hahné SJM, Van Els CACM, Boland GJ, Vossen ACTM, Goswami PR, et al. Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students. Open Forum Infect Dis. 2014;1(3):ofu101. doi:10.1093/ofid/ofu101.
  • Shoho Y, Kimura T, Yanagawa Y, Saito A, Inoue T, Suto C, Tsunekawa K, Araki O, Nara M, Tokue Y, et al. Vaccination status and antibody titers against rubella and measles among Japanese female college students majoring in childcare between 2015 and 2018. Tohoku J Exp Med. 2018;246(2):73–79. doi:10.1620/tjem.246.73.
  • Sasaki H, Fukunaga T, Asano A, Suzuki Y, Nakanishi Y, Kondo J, Ishikawa H, Shibata N. A survey of vaccine-induced measles IgG antibody titer to verify temporal changes in response to measles vaccination in young adults. Vaccines (Basel). 2019;7(3):E118. doi:10.3390/vaccines7030118.
  • Castillo-Solórzano C, Marsigli C, Bravo-Alcántara P, Flannery B, Ruiz Matus C, Tambini G, Gross-Galiano S, Andrus JK. Elimination of rubella and congenital rubella syndrome in the Americas. J Infect Dis. 2011;204(suppl suppl_2):S571–S578. doi:10.1093/infdis/jir472.
  • Sasaki H, Fukunaga T, Asano A, Tsumita M, Suzuki Y, Shibata N. Persistence of anti-rubella immunoglobulin G antibody titers in young adults involved in a short-term periodic immunization in Japan. Jpn J Infect Dis. 2021 (in press). doi: 10.7883/yoken.JJID.2020.542.
  • Kitano T. Close the gap for routine mumps vaccination in Japan. Hum Vaccines Immunother. 2021;17(1):205–10. doi:10.1080/21645515.2020.1765619.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.